Reletter
Artwork for Sharpe Two

Sharpe Two

Ksander

Volatility research lab - We bring high Sharpe ratio trading ideas to retail traders and low-capacity investors. No PhD required.

Platform
Substack
PricingFreemiumPublishesDaily
Issues149SubscribersRead sharpetwo.com

Curious about how many subscribers Sharpe Two has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.

Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.

Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.

Contact Information
How Many Subscribers?
Reletter gives you subscriber numbers, contacts, chart rankings, traffic estimates and more across 1.6m+ newsletters.

Chart Rankings

How this newsletter ranks in the official Substack charts.

#232
Substack
/Finance(Paid)

Latest Issues

Recent posts by this newsletter. Browse the email archive.

Signal Du Jour - survive the spike.

Markets are tumbling in the continuation of the moves observed last Friday. VIX is currently trading around 60, while the SP500 futures point toward a -3% at the open. The Nasdaq is (so far) off the lows we’ve seen during the European sessi...

a month ago
11
0

Forward Note - 2024/08/04

If you are a new reader of Sharpe Two, I’d rather warn you now: we suck. Here is an extract of our Forward Note from two weeks ago.

a month ago
9
0

Signal Du Jour - short vol in USO

Staying clear of the equity market frenzy

2 months ago
9
0
Paid

Forward Note - 2024/07/28

You have two ways of looking at what happened in the market this week: small and mid-caps finished up 3.65% (IWM), while the Nasdaq lost 2.65% (QQQ). Similarly, the VIX closed above 16 for the second week, yet far from the highest readings ...

2 months ago
11
0

Authors

The writers behind this newsletter.

  • Ksander

    Ksander, founder of Sharpe Two, combines finance and data science for innovative trading strategies. Former options trader and AI startup leader, he leverages market intelligence and data to uncover trading inefficiencies.

  • Frequently Asked Questions

    How can I access the email archive for Sharpe Two?

    You can find recent issues that have been published by Sharpe Two on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.

    How many subscribers does Sharpe Two have?

    To see how many people subscribe to Sharpe Two, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.

    How can I advertise in Sharpe Two?

    Newsletter advertising can be extremely effective when it's done right. Before you pitch Sharpe Two as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.

    Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.

    How much does it cost to sponsor a publication like Sharpe Two?

    Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.

    To find out how much an ad will cost, contact Sharpe Two using the contact information provided and ask for a copy of their media kit.

    How can I find newsletters similar to Sharpe Two?

    Scroll up to where it says Similar Newsletters to see other publications like Sharpe Two. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.

    How do I contact Sharpe Two?

    Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.